AndreaBozzo/ceres-open-data-index huggingface dataset:
Patent AT-E399743-T1: [Translated] GLAZING PROVIDED WITH A THIN-LAYER STRUCTURE THAT EFFECTS SOLAR RADIATION

A coated transparent substrate has a metallic or nitrided niobium, tantalum and/or zirconium functional layer and an aluminum and/or silicon nitride and/or oxynitride cover layer. A transparent substrate has a solar radiation active thin film stack comprising a functional layer based on metallic or partially or fully nitrided niobium, tantalum and/or zirconium covered by a layer based on aluminum nitride, aluminum oxynitride, silicon nitride and/or silicon oxynitride. Independent claims are also included for the following: (i) single or double glazing incorporating the above substrate; and (ii) a curtain wall-type facade face panel incorporating the above substrate with an opaque coating. Preferred Features: The substrate consists of clear or tinted glass or a flexible or rigid transparent polymer.
Human Centered Design, User Experience, and Lived Experience CCWIS Toolkit

This technical assistance document provides guidance around the human centered design (HCD) methodology, user experience (UX) methods and outcomes, integrating HCD and UX into Comprehensive Child Welfare Information Systems (CCWIS), incorporating Lived Experience into UX, user research methods, and how to request technical assistance around these concepts.

Metadata-only record linking to the original dataset. Open original dataset below.
Evaluating our end-of-life practice

Ferrand et al's recent study of witholding and withdrawing life support in intensive care units in France reminds us that reporting end-of-life practices is an important step towards enhancing end-of-life care. The study highlights differences between the parentalistic approach to decision making in Europe, and the patient autonomy model in the USA. However, the reasons intensivists report for witholding or withdrawing life support are similar in both cultures. Intensivists in France make decisions despite a lack of formal guidelines in their country. This study should serve as a stimulus for educating the public and motivating more groups to monitor their end-of-life practices.
The vasculature and its role in the damaged and healing tendon

Tendon pathology has many manifestations, from spontaneous rupture to chronic tendinitis or tendinosis; the etiology and pathology of each are very different, and poorly understood. Tendon is a comparatively poorly vascularised tissue that relies heavily upon synovial fluid diffusion to provide nutrition. During tendon injury, as with damage to any tissue, there is a requirement for cell infiltration from the blood system to provide the necessary reparative factors for tissue healing. We describe in this review the response of the vasculature to tendon damage in a number of forms, and how and when the revascularisation or neovascularisation process occurs. We also include a section on the revascularisation of tendon during its use as a tendon graft in both ligament reconstruction and tendon–tendon grafting.
Compound 528291: Benzene, 1,2,4-trimethyl-3-propyl

Chemical compound data from PubChem database. IUPAC Name: 1,2,4-trimethyl-3-propylbenzene. Molecular Formula: C12H18. Molecular Weight: 162.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525573: N,N-Dimethyl-N'-(3-methoxyphenyl)-benzamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(3-methoxyphenyl)-N,N-dimethylbenzenecarboximidamide. Molecular Formula: C16H18N2O. Molecular Weight: 254.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Health Services Research Projects in Progress (HSRProj)

Health Services Research Projects in Progress (HSRProj) was a database of health services research and public health projects in progress, related to research in quality, cost, and access to health care. It included behavioral health research and public health research, with over 38,000 projects and information back to the 1990s.

This resource was retired on September 14, 2021 and is no longer updated.
Patent AT-E400674-T1: [Translated] COLD SPRAYING SYSTEM AND COLD SPRAYING PROCESS WITH MODULATED GAS FLOW

The cold gas spray apparatus (1) has a high pressure gas generator (22) for the production of a high pressure gases and a nozzle (8) from which a cold gas particle stream (7) is emitted. An influencing medium (25,26,29,32,35,36) is provided. The cold gas particle stream is guided for variable modification of the characteristics temperature, pressure, particle density, particle material and velocity. A property of the cold gas particle stream is periodically modifiable by influencing medium. An independent claim is also included for a cold gas spraying method by the cold gas spray apparatus.
High calcium and dobutamine positive inotropy in the perfused mouse heart: myofilament calcium responsiveness, energetic economy, and effects of protein kinase C inhibition

Background
          In perfused hearts, high calcium-induced inotropy results in less developed pressure relative to myocardial oxygen consumption compared to the β-adrenergic agonist dobutamine. Calcium handling is an important determinant of myocardial oxygen consumption. Therefore, we hypothesized that this phenomenon was due to reduced myofilament responsiveness to calcium, related to protein kinase C activation.
        
        
          Results
          Developed pressure was significantly higher with dobutamine compared to high perfusate calcium of 3.5 mM (73 ± 10 vs 63 ± 10 mmHg, p < 0.05), though peak systolic intracellular calcium was not significantly different, suggesting reduced myofilament responsiveness to intracellular calcium with high perfusate calcium. The ratio of developed pressure to myocardial oxygen consumption, an index of economy of contraction, was significantly increased with dobutamine compared to high perfusate calcium (1.35 ± 0.15 vs 1.15 ± 0.15 mmHg/μmoles/min/g dry wt, p < 0.05), suggesting energetic inefficiency with high perfusate calcium. The specific protein kinase C inhibitor, chelerythrine, significantly attenuated the expected increase in developed pressure when increasing perfusate calcium from 2.5 to 3.5 mM (3.5 mM: 64 ± 8 vs 3.5 mM + chelerythrine: 55 ± 5 mmHg, p < 0.05), though had no effects on dobutamine, or lower levels of perfusate calcium (1.5 to 2.5 mM).
        
        
          Conclusions
          By measuring intracellular calcium, developed pressures and myocardial oxygen consumption in perfused mouse hearts, these results demonstrate that high perfusate calcium positive inotropy compared to dobutamine results in reduced myofilament responsiveness to intracellular calcium, which is associated with energetic inefficiency and evidence of protein kinase C activation.
2013 CMHS Uniform Reporting System (URS) Tables for Illinois

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for Illinois for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
District of Columbia 2016 Potential Areas for Addressing Service Gaps for Opioid Treatment

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are also informed. The maps are meant to be used as a tool for policy makers to determine potentially underserved areas—not as a definitive representation of these areas.
Evaluation Plan Outline

This document outlines what should be included in the Evaluation Plan, which is due 90 days after the agency awards its evaluation contract. Based on a review of the literature and discussions with experts in the field, ACYF and OPRE have compiled a list of screening and assessment instruments to measure child and adolescent well-being and trauma. The tables in this document provide information about instruments that may be useful to title IV-E agencies that are looking to implement or expand the use of screening and functional assessment for ongoing practice and waiver demonstration evaluations. The tables will be updated as more information becomes available on reliable and valid screening and assessment instruments that are applicable in a child welfare context.

Metadata-only record linking to the original dataset. Open original dataset below.
Seattle: Drug-Related Emergency Department Visits, 2004-2011 - All Misuse and Abuse

Excel file with estimates, rates, relative standard errors, trends and confidence intervals for all drug-related emergency department (ED) visits involving drug misuse or abuse in the Seattle metropolitan area, covering 2004-2011. Drug misuse/abuse visits include the use of illicit drugs, nonmedical use of pharmaceuticals, underage drinking and visits where alcohol was combined with another drug.
Compound 525667: p-Bromobenzylidene-cyclohexyl-amine

Chemical compound data from PubChem database. IUPAC Name: 1-(4-bromophenyl)-N-cyclohexylmethanimine. Molecular Formula: C13H16BrN. Molecular Weight: 266.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401759-T1: [Translated] INSERT MODULE FOR MINIATURE HEARING AID

According to the present invention, there is provided a hearing aid insert module comprising a socket module, and a substantially closed-loop frame comprising electrically conductive portions, the closed-loop frame further comprising engaging means adapted to releasably coupling the hearing aid insert module to a faceplate of a hearing aid.  The invention is of advantage in that releasable coupling of the faceplate to the socket module via the frame is capable of rendering the insert module easier to manufacture, to user-customize and to repair. The frame is arranged to impart a majority of structural rigidity to the faceplate when inserted therein. Such rigidity is of benefit in that the faceplate is capable in use of applying a flexural component to the frame which could damage the frame if not of sufficiently substantial rigidity.
Comparative efficacy of two microdoses of a potentized homoeopathic drug, Cadmium Sulphoricum, in reducing genotoxic effects produced by cadmium chloride in mice: a time course study

Background
          Cadmium poisoning in the environment has assumed an alarming problem in recent years. Effective antimutagenic agents which can reverse or combat cadmium induced genotoxicity in mice have not yet been reported. Therefore, in the present study, following the homeopathic principle of "like cures like", we tested the efficacy of two potencies of a homeopathic drug, Cadmium Sulphoricum (Cad Sulph), in reducing the genotoxic effects of Cadmium chloride in mice.
          Another objective was to determine the relative efficacy of three administrative modes, i.e. pre-, post- and combined pre and post-feeding of the homeopathic drugs. For this, healthy mice, Mus musculus, were intraperitoneally injected with 0.008% solution of CdCl2 @ 1 ml/100 gm of body wt (i.e. 0.8 mcg/gm of bw), and assessed for the genotoxic effects through such studies as chromosome aberrations (CA), micronucleated erythrocytes (MNE), mitotic index (MI) and sperm head anomaly (SHA), keeping suitable succussed alcohol fed (positive) and CdCl2 untreated normal (negative) controls. The CdCl2 treated mice were divided into 3 subgroups, which were orally administered with the drug prior to, after and both prior to and after injection of CdCl2 at specific fixation intervals and their genotoxic effects were analyzed.
        
        
          Results
          While the CA, MNE and SHA were reduced in the drug fed series as compared to their respective controls, the MI showed an apparent increase. The combined pre- and post-feeding of Cad Sulph showed maximum reduction of the genotoxic effects.
        
        
          Conclusions
          Both Cad Sulph-30 and 200 were able to combat cadmium induced genotoxic effects in mice and that combined pre- and post-feeding mode of administration was found to be most effective in reducing the genotoxic effect of CdCl2 followed by the post-feeding mode.
Patent AT-E400516-T1: [Translated] TAMPER-RESISTANT AND CHILD-RESISTANT TABLET DISPENSER WITH EJECTOR

Tamper and child proof dispenser for a solid dosage product such as tablets and capsules that may be contained in a blister sheet. Dispenser comprises a dispensing assembly ( 3 ) for holding and dispensing the product, a slidably or hingedly connected outercover ( 1 ) for covering the assembly to prevent access to the product, and tamper indication means ( 7 ) of an elongate removable tag for indicating a prior displacement of the outer cover. The dispenser has an external child proof button ( 9 ) supported on a tongue ( 10 ). The dispensing assembly has an ejection means of a slide actuation mechanism ( 57 ) including an actuation arm ( 59 ) upon which is mounted a slidable rider member ( 61 ) with an abutment to engage and eject the solid dosage product. The outer cover has four separable portions ( 67 ) which are individually removed to enable a particular actuation mechanism ( 57 ) to be moved for dispensing a product.
Patent AT-E401368-T1: [Translated] METHOD FOR JOINING TWO SUBSTRATES USING GLUE AND METHOD FOR DISASSEMBLING THE BONDED ARRANGEMENT USING MIGRATION

The invention relates to a method of assembling a first substrate (10) and a second substrate (12) by means of bonding with at least one joint (14). The invention is characterised in that it comprises the following successive steps consisting in: positioning at least one polymer joint (14) between the first (10) and second (12) substrates, said at least one joint comprising at least one migrating agent which can migrate to at least one of the interfaces of the at least one joint in order to generate a layer with low cohesion; pressing the two substrates (10, 12) against one another; and polymerising the at least one joint (14) in order to obtain a bonded assembly comprising said two substrates (10, 12).
Alveolar epithelial type II cell: defender of the alveolus revisited

In 1977, Mason and Williams developed the concept of the alveolar epithelial type II (AE2) cell as a defender of the alveolus. It is well known that AE2 cells synthesise, secrete, and recycle all components of the surfactant that regulates alveolar surface tension in mammalian lungs. AE2 cells influence extracellular surfactant transformation by regulating, for example, pH and [Ca2+] of the hypophase. AE2 cells play various roles in alveolar fluid balance, coagulation/fibrinolysis, and host defence. AE2 cells proliferate, differentiate into AE1 cells, and remove apoptotic AE2 cells by phagocytosis, thus contributing to epithelial repair. AE2 cells may act as immunoregulatory cells. AE2 cells interact with resident and mobile cells, either directly by membrane contact or indirectly via cytokines/growth factors and their receptors, thus representing an integrative unit within the alveolus. Although most data support the concept, the controversy about the character of hyperplastic AE2 cells, reported to synthesise profibrotic factors, proscribes drawing a definite conclusion today.
Compound 528386: 3,4-Dichloro-2-hydroxybenzaldehyde

Chemical compound data from PubChem database. IUPAC Name: 3,4-dichloro-2-hydroxybenzaldehyde. Molecular Formula: C7H4Cl2O2. Molecular Weight: 191.01. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Court Improvement Program

Section 438 of Title IV-B, subpart 2 of the Social Security Act sets aside funding for the Court Improvement Program (CIP).   The State CIP is a mandatory formula grant available to the highest court of appeal in every state, the District of Columbia, Puerto Rico and the U.S. Virgin Islands.  The purpose of the CIP is to: (1) promote the continuous quality improvement of court processes and legal representation in child welfare proceedings through ongoing data analysis, assessment, interventions and training, and (2) enhance and expand collaboration between the judicial branch of state government, the title IV-E/IV-B agency and tribes to improve child welfare outcomes.  In addition to the State CIP formula grants, approximately $1 million is set aside for Tribal CIP. These funds are awarded competitively.

The formula for the State CIP grants provides State courts with an approved application, a $255,000 base allotment plus, after the sum of all states’ base amounts and the $1 million set aside for grants to tribes are subtracted from the total appropriation, a percentage of the remainder based on the state’s proportionate share of children under age 21.

Budget Information:FY 2024 Funding:  approximately $31 million

Metadata-only record linking to the original dataset. Open original dataset below.
A rate equation model of stomatal responses to vapour pressure deficit and drought

Background
          Stomata respond to vapour pressure deficit (D) – when D increases, stomata begin to close. Closure is the result of a decline in guard cell turgor, but the link between D and turgor is poorly understood. We describe a model for stomatal responses to increasing D based upon cellular water relations. The model also incorporates impacts of increasing levels of water stress upon stomatal responses to increasing D.
        
        
          Results
          The model successfully mimics the three phases of stomatal responses to D and also reproduces the impact of increasing plant water deficit upon stomatal responses to increasing D. As water stress developed, stomata regulated transpiration at ever decreasing values of D. Thus, stomatal sensitivity to D increased with increasing water stress. Predictions from the model concerning the impact of changes in cuticular transpiration upon stomatal responses to increasing D are shown to conform to experimental data.
          Sensitivity analyses of stomatal responses to various parameters of the model show that leaf thickness, the fraction of leaf volume that is air-space, and the fraction of mesophyll cell wall in contact with air have little impact upon behaviour of the model. In contrast, changes in cuticular conductance and membrane hydraulic conductivity have significant impacts upon model behaviour.
        
        
          Conclusion
          Cuticular transpiration is an important feature of stomatal responses to D and is the cause of the 3 phase response to D. Feed-forward behaviour of stomata does not explain stomatal responses to D as feedback, involving water loss from guard cells, can explain these responses.
Compound 530489: m-Anisic acid, 2-(1-adamantyl)ethyl ester

Chemical compound data from PubChem database. IUPAC Name: 2-(1-adamantyl)ethyl 3-methoxybenzoate. Molecular Formula: C20H26O3. Molecular Weight: 314.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
The genetics of rheumatoid arthritis and the need for animal models to find and understand the underlying genes

The causes of rheumatoid arthritis (RA) are largely unknown. However, RA is most probably a multifactorial disease with contributions from genetic and environmental factors. Searches for genes that influence RA have been conducted in both human and experimental model materials. Both types of study have confirmed the polygenic inheritance of the disease. It has become clear that the features of RA complicate the human genetic studies. Animal models are therefore valuable tools for identifying genes and determining their pathogenic role in the disease. This is probably the fastest route towards unravelling the pathogenesisis of RA and developing new therapies.
Patent AT-E400100-T1: [Translated] DEVICE FOR MEASURING AND COMPENSATING COLOR DISPERSION

The invention proposes a technique for measuring chromatic dispersion in an optical communication line transmitting an optical signal at a predetermined optical wavelength. The technique comprises determining the sign of chromatic dispersion and includes introducing controlled changes of wavelength around the predetermined wavelength, monitoring the optical signal that has passed said line, and obtaining a first and a second signals, wherein the first signal reflects changes of the carrier wavelength, and the second signal reflects changes of delay of the optical signal transmitted via the line. The two signals are compared and the chromatic dispersion sign is determined based on the phase difference there-between.
Compound 525470: 4,6-Dithia-1,8-nonadiene

Chemical compound data from PubChem database. IUPAC Name: 3-(prop-2-enylsulfanylmethylsulfanyl)prop-1-ene. Molecular Formula: C7H12S2. Molecular Weight: 160.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530715: o-Anisic acid, 2-methyloct-5-yn-4-yl ester

Chemical compound data from PubChem database. IUPAC Name: 2-methyloct-5-yn-4-yl 2-methoxybenzoate. Molecular Formula: C17H22O3. Molecular Weight: 274.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527185: 1-((2R,8R,8aS)-8,8a-Dimethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)ethanone

Chemical compound data from PubChem database. IUPAC Name: 1-(8,8a-dimethyl-2,3,4,6,7,8-hexahydro-1H-naphthalen-2-yl)ethanone. Molecular Formula: C14H22O. Molecular Weight: 206.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527313: Methyl 2-[3-(4-methoxyphenoxy)phenyl]propanoate

Chemical compound data from PubChem database. IUPAC Name: methyl 2-[3-(4-methoxyphenoxy)phenyl]propanoate. Molecular Formula: C17H18O4. Molecular Weight: 286.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.